Product Launch Webinar: Key Considerations for your Gene Therapy Product Launch
The presenters review areas such as developing bespoke packaging processes to facilitate in most cases, Ultra Low Temperature handling requirements and the various Just in Time supply chain models. Ian joins the Almac team to share his real-life experience of successfully launching Zolgensma onto the EU market including the approach Novartis Gene Therapies took to ensure a smooth launch and what lessons were learnt along the way.
Speakers: Robert O’Brien, Head of Technical Support and Ian Mussen, Head of Supply Chain EMEA, Novartis Gene TherapiesView Resource
Almac Pharma Services provide a wide range of customised commercial services from supporting product launch, manufacturing and / or packaging drug product, to securing supply chain with global serialisation solutions.
Our flexible, quality-led commercial solutions range from orphan drug launches to ongoing high-volume commercial product manufacture, packaging and supply.